Risk of Pacing-Induced Cardiomyopathy in Patients with High-Degree Atrioventricular Block—Impact of Right Ventricular Lead Position Confirmed by Computed Tomography

Autor: Patricia Zerlang Fruelund, Anders Sommer, Jens Brøndum Frøkjær, Søren Lundbye-Christensen, Tomas Zaremba, Peter Søgaard, Claus Graff, Søren Vraa, Aksayan Arunanthy Mahalingasivam, Anna Margrethe Thøgersen, Michael Rangel Pedersen, Sam Riahi
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Fruelund, P Z, Sommer, A, Frøkjær, J B, Lundbye-Christensen, S, Zaremba, T, Søgaard, P, Graff, C, Vraa, S, Mahalingasivam, A A, Thøgersen, A M, Pedersen, M R & Riahi, S 2022, ' Risk of Pacing-Induced Cardiomyopathy in Patients with High-Degree Atrioventricular Block—Impact of Right Ventricular Lead Position Confirmed by Computed Tomography ', Journal of Clinical Medicine, vol. 11, no. 23, 7228 . https://doi.org/10.3390/jcm11237228
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7228
DOI: 10.3390/jcm11237228
Popis: Prospective studies applying fluoroscopy for assessment of right ventricular (RV) lead position have failed to show clear benefits from RV septal pacing. We investigated the impact of different RV lead positions verified by computed tomography (CT) on the risk of pacing-induced cardiomyopathy (PICM). We retrospectively included 153 patients who underwent routine fluoroscopy-guided pacemaker implantation between March 2012 and May 2020. All patients had normal pre-implant left ventricular ejection fraction (LVEF). Patients attended a follow-up visit including contrast-enhanced cardiac CT and transthoracic echocardiography. Patients were classified as septal or non-septal based on CT analysis. The primary endpoint was PICM (LVEF < 50% with ≥10% decrease after implantation). Based on CT, 48 (31.4%) leads were septal and 105 (68.6%) were non-septal. Over a median follow-up of 3.1 years, 16 patients (33.3%) in the septal group developed PICM compared to 31 (29.5%) in the non-septal group (p = 0.6). Overall, 13.1% deteriorated to LVEF ≤ 40%, 5.9% were upgraded to cardiac resynchronization therapy device, and 14.4% developed new-onset atrial fibrillation, with no significant differences between the groups. This study demonstrated a high risk of PICM despite normal pre-implant left ventricular systolic function with no significant difference between CT-verified RV septal or non-septal lead position.
Databáze: OpenAIRE